Kelly Dunn

Kelly Dunn, MD, is a physician board-certified in psychiatry and addiction medicine who serves as Chief of Addiction Medicine, Vice Chair of Psychiatry and Behavioral Sciences, and Associate Clinical Professor at Oklahoma State University Center for Health Sciences. Her work connects clinical innovation, research, education, and advocacy to expand access to effective substance use disorder treatment.

Dr. Dunn brings experience leading multidisciplinary teams and translating strategic priorities into clinical services and collaborative programs. She has developed outpatient addiction treatment, expanded virtual specialty care to more than a dozen locations across Oklahoma, and launched integrated maternal addiction care and transcranial magnetic stimulation services. Her leadership spans clinical service line development, grant and project management, operational implementation, and partnerships across academic, healthcare, and community organizations.

As a clinical investigator, Dr. Dunn has served as lead medical investigator on trials evaluating novel addiction treatments, including semaglutide and pemvidutide for alcohol use disorder and continues to explore the role of GLP-1 type medications in substance use tretment. In addition, her interests include brain stimulation approaches for substance use disorders and integrating emerging treatments into clinical practice. She also advances addiction care through medical education, physician workforce development, public policy engagement, and research addressing stigma.